MedPath

Development of a New Method for Liver Stiffness Measurement Using FibroScan

Not Applicable
Not yet recruiting
Conditions
Liver Diseases
Interventions
Device: Research FibroScan (FS)
Registration Number
NCT06519331
Lead Sponsor
Echosens
Brief Summary

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
114
Inclusion Criteria
  • Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
  • Adult patient able to give his written consent
  • Patient affiliated to the French Social Security system
Exclusion Criteria
  • Vulnerable patients
  • Patients with liver ascites
  • Patients with heart failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adult patient (age >= 18 y.o) followed for a liver disease, all etiologies combinedResearch FibroScan (FS)Adult patients followed in the Hepatology or Endocrinology department for a liver disease, suspected chronic liver disease or consequences of chronic liver disease, all etiologies combined.
Primary Outcome Measures
NameTimeMethod
Reduced intra-examination dispersion of liver stiffness measurements with the new measurement method.24 months
Secondary Outcome Measures
NameTimeMethod
Bias between the estimated reference stiffness repetitions and between the stiffness at rest repetitions.24 months

Intra-class correlation coefficients will be done.

Bias between the different stiffness measurements (reference/estimated reference/at rest)24 months

Correlation coefficients will be done.

Bias between the CAP measured with the Research FibroScan and the CAP measured with the Reference FibroScan24 months

Correlation coefficients will be done.

Bias between the CAP repetitions done with the Research FibroScan24 months

Intra-class correlation coefficients will be done.

Trial Locations

Locations (2)

Groupe Hospitalier Nord Essonne - Site Paris- Saclay

🇫🇷

Orsay, France

Hôpital Pitié-Salpêtrière

🇫🇷

Paris, Ile De France, France

© Copyright 2025. All Rights Reserved by MedPath